IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal CancerO. De Simoni, Mario Guerrieri, Imerio Angriman et al.|Cancers|2026Cited by 3
68 IMMUNOREACT 13: IMMUNE SURVEILLANCE MARKERS IN THE CLINICAL MANAGEMENT OF STAGE II RECTAL CANCERGiorgio Rivella, Marco Scarpa, Melania Scarpa et al.|Gastroenterology|2024Cited by 0
IMMUNOREACT 13: immune features of healthy rectal mucosa as predictors of invasion risk in stage II rectal cancerGiorgio Rivella, Michele Antoniutti, Melania Scarpa et al.|British journal of surgery|2025Cited by 0
Familial colorectal cancer history is associated with an altered immune–genomic profile in microsatellite-stable rectal cancer: a prospective multicentre cohort studySilvia Negro, Monica Ortenzi, Melania Scarpa et al.|SSRN Electronic Journal|2026Cited by 0
Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?—The IMMUNOREACT 20 StudyLorenzo Dell’Atti, Mario Guerrieri, Andromachi Kotsafti et al.|Cancers|2026Cited by 0